These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36798606)

  • 1. Estimating Carbon Dioxide Emissions and Direct Power Consumption of Linear Accelerator-Based External Beam Radiation Therapy.
    Shenker RF; Johnson TL; Ribeiro M; Rodrigues A; Chino J
    Adv Radiat Oncol; 2023; 8(3):101170. PubMed ID: 36798606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Carbon Footprint of Proton Therapy Based on Power Consumption and Possible Mitigation Strategies.
    Dvorak T; Meeks S; Dvorak L; Rineer J; Kelly P; Ramakrishna N; Henig T; Kucukvar M; Onat NC; Tatari O; Shah A; Salazar J; Zeidan O
    Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):22-30. PubMed ID: 37244624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventional Imaging Systems in Radiology, Cardiology, and Urology: Energy Consumption, Carbon Emissions, and Electricity Costs.
    Vosshenrich J; Mangold D; Aberle C; Cerminara A; Seifert HH; Osswald S; Merkle EM; Heye T
    AJR Am J Roentgenol; 2024 Jun; 222(6):e2430988. PubMed ID: 38506540
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantification of the environmental impact of radiotherapy and associated secondary human health effects: a multi-institutional retrospective analysis and simulation.
    Lichter KE; Charbonneau K; Lewy JR; Bloom JR; Shenker R; Sabbagh A; Chino J; Rodrigues A; Hearn J; Grover S; Sheu RD; Witztum A; Qureshi MM; Yom SS; Anand C; Thiel CL; Mohamad O
    Lancet Oncol; 2024 Jun; 25(6):790-801. PubMed ID: 38821084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer.
    Phak JH; Kim HJ; Kim WC
    Prostate Int; 2016 Mar; 4(1):25-9. PubMed ID: 27014661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The carbon footprint of external beam radiotherapy and its impact in health technology assessment.
    Dupraz C; Ducrot C; Allignet B; Delpon G; Alexis A; Lapierre A; Supiot S; Ali D; Piffoux M
    Clin Transl Radiat Oncol; 2024 Sep; 48():100834. PubMed ID: 39211397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.
    Repka MC; Aghdam N; Kataria SK; Campbell L; Suy S; Collins SP; Anderson E; Lischalk JW; Collins BT
    Radiat Oncol; 2017 Oct; 12(1):162. PubMed ID: 29052514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir.
    Anwar M; Weinberg V; Chang AJ; Hsu IC; Roach M; Gottschalk A
    Radiat Oncol; 2014 Feb; 9():42. PubMed ID: 24484652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
    Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
    Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806).
    Isfahanian N; Lukka H; Dayes I; Quan K; Schnarr KL; Douvi G; Goldberg M; Wright J; Swaminath A; Chow T; Diamond K; Cutz JC; Kavsak P; Thabane L; Tsakiridis T
    Clin Genitourin Cancer; 2020 Aug; 18(4):e410-e415. PubMed ID: 32265129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer.
    Avkshtol V; Dong Y; Hayes SB; Hallman MA; Price RA; Sobczak ML; Horwitz EM; Zaorsky NG
    Res Rep Urol; 2016; 8():145-58. PubMed ID: 27574585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer.
    Lee SH; Kim HJ; Kim WC
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):388-395. PubMed ID: 27461444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
    Lanni TB; Grills IS; Kestin LL; Robertson JM
    Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate SBRT using O-Ring Halcyon Linac - Plan quality, delivery efficiency, and accuracy.
    Pokhrel D; Tackett T; Stephen J; Visak J; Amin-Zimmerman F; McGregor A; Strup SE; St Clair W
    J Appl Clin Med Phys; 2021 Jan; 22(1):68-75. PubMed ID: 33340388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT.
    Coombs NJ; Coombs JM; Vaidya UJ; Singer J; Bulsara M; Tobias JS; Wenz F; Joseph DJ; Brown DA; Rainsbury R; Davidson T; Adamson DJ; Massarut S; Morgan D; Potyka I; Corica T; Falzon M; Williams N; Baum M; Vaidya JS
    BMJ Open; 2016 May; 6(5):e010703. PubMed ID: 27160842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Radiation Therapy for Bone Metastases, 2015 to 2017: Choosing Wisely in the Era of Complex Radiation.
    Santos PMG; Lapen K; Zhang Z; Lobaugh S; Tsai CJ; Yang TJ; Bekelman JE; Gillespie EF
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):923-931. PubMed ID: 33188862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustainability in radiation oncology: opportunities for enhancing patient care and reducing CO
    Bedir A; Grohmann M; Schäfer S; Mäurer M; Weimann S; Roers J; Hering D; Oertel M; Medenwald D; Straube C
    Strahlenther Onkol; 2024 Sep; ():. PubMed ID: 39317752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linac-based stereotactic body radiation therapy for treatment of glomus jugulare tumors.
    Wegner RE; Rodriguez KD; Heron DE; Hirsch BE; Ferris RL; Burton SA
    Radiother Oncol; 2010 Dec; 97(3):395-8. PubMed ID: 20950881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of using ring-mounted Halcyon Linac for single-isocenter/two-lesion lung stereotactic body radiation therapy.
    Pokhrel D; Webster A; Mallory R; Visak J; Bernard ME; McGarry RC; Kudrimoti M
    J Appl Clin Med Phys; 2022 May; 23(5):e13555. PubMed ID: 35128795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.